An underground economy for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Investigational Drug Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are urged to message these accounts directly for supplier links, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a robust market exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Sellers market the drug there before directing customers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Professionals Voice Concerns
Nevertheless, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.
Several experts said the demand for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.
Some influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer laws, risking fines, prosecution or prison.
Service Response and Content Removal
According to TikTok, the platform has taken down violative material and prohibited associated hashtags and search suggestions. The organization stated it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also discovered communities with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at residence.
After minutes of joining one community, a seller shared WhatsApp details, where most transactions occur. The vendor provided an instruction manual and promised delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.
Item Information and Costs
Inside these groups, messages display black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled pens typically priced at £160 for 20mg. When asked how long a injector should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A representative for Telegram said it regularly moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting materials they cannot confirm. Although the research behind this drug is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.
Her staff has previously encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may subject patients to possibly serious health risks”.
